Participating Faculty

Supplements and Featured Publications, Update on the Diagnosis and Treatment of Gout, Volume 11, Issue 15 Suppl

This supplement to The American Journal of Managed Care provides information on risk factors for hyperuricemia and gout, the incidence and prevalence of these conditions, approaches to the diagnosis of gout, pharmacologic and nonpharmacologic treatments for gout, and clinical, humanistic, and economic outcomes of gout.

Faculty

Diana I. Brixner, RPh, PhDAssociate Professor and Chair

Executive Director, Pharmacotherapy Outcomes Research Center

Salt Lake City

Amy C. Cannella, MD

Section of Rheumatology and Immunology

Omaha

Mei-Jen Ho, PharmDFellow and MPH Candidate

Pharmacotherapy Outcomes Research Center

Salt Lake City

Andrew J. Luk, MD, MPHActing Chief of Rheumatology

University of Washington

Seattle

Ted R. Mikuls, MD, MSPH

Section of Rheumatology and Immunology

Omaha

Naomi Schlesinger, MD

Department of Medicine

New Brunswick, NJ

Peter A. Simkin, MD

Division of Rheumatology

Seattle

Disclosure Statement

It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. The following participants report relationships with pharmaceutical companies:

Diana I. Brixner, RPh, PhDResearch/Grant Support From/Consultation/Speakers' Bureau For:Bristol-Myers Squibb

Sanofi-Aventis

Research Support From:

Pfizer

Abbott

NPS

Watson

Ted R. Mikuls, MD, MSPH

TAP

Peter A. Simkin, MDSpeakers' Bureau For:Fallon Medica

Amy C. Cannella, MD Mei-Jen Ho, PharmD

Naomi Schlesinger, MD

Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.